The History and Use of Human Hepatocytes for the Treatment of Liver Diseases: The First 100 Patients

Marc C. Hansel1, Roberto Gramignoli2, Kristen J. Skvorak3, Kenneth Dorko4, Fabio Marongiu5, William Blake6, Julio Davila7, Stephen C. Strom2

1 McGowan Institute for Regenerative Medicine, Pittsburgh, Pennsylvania, 2 Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, 3 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 4 Department of Pharmacology, Toxicology and Therapeutics, Kansas University Medical Center, Kansas City, Kansas, 5 Department of Biomedical Sciences, Section of Experimental Pathology, Unit of Experimental Medicine, University of Cagliari, Cagliari, 6 Genetically Modified Models Center of Emphasis, Pfizer, Groton, Connecticut, 7 Department of Biochemistry, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
Publication Name:  Current Protocols in Toxicology
Unit Number:  Unit 14.12
DOI:  10.1002/0471140856.tx1412s62
Online Posting Date:  November, 2014
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library


Orthotopic liver transplantation remains the only curative treatment for many end‐stage liver diseases, yet the number of patients receiving liver transplants remains limited by the number of organs available for transplant. There is a need for alternative therapies for liver diseases. The transplantation of isolated hepatocytes (liver cells) has been used as an experimental therapy for liver disease in a limited number of cases. Recently, the 100th case of hepatocyte transplantation was reported. This review discusses the history of the hepatocyte transplant field, the major discoveries that supported and enabled the first hepatocyte transplants, and reviews the cases and outcomes of the first 100 clinical transplants. Some of the problems that limit the application or efficacy of hepatocyte transplantation are discussed, as are possible solutions to these problems. In conclusion, hepatocyte transplants have proven effective particularly in cases of metabolic liver disease where reversal or amelioration of the characteristic symptoms of the disease is easily quantified. However, no patients have been completely corrected of a metabolic liver disease for a significant amount of time by hepatocyte transplantation alone. It is likely that future developments in new sources of cells for transplantation will be required before this cellular therapy can be fully implemented and available for large numbers of patients. © 2014 by John Wiley & Sons, Inc.

Keywords: hepatocyte; hepatocyte transplantation; liver disease; metabolic liver disease; cellular therapy; cell therapy; regenerative medicine

PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Literature Cited
  • Figures
  • Tables
PDF or HTML at Wiley Online Library


PDF or HTML at Wiley Online Library



Literature Cited

Literature Cited
  Allen, K.J., Mifsud, N.A., Williamson, R., Bertolino, P., and Hardikar, W. 2008. Cell‐mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl. 14:688‐694.
  Ambrosino, G., Varotto, S., Strom, S.C., Guariso, G., Franchin, E., Miotto, D., Caenazzo, L., Basso, S., Carraro, P., Valente, M.L., D'Amico, D., Zancan, L., and D'Antiga, L. 2005. Isolated hepatocyte transplantation for Crigler‐Najjar syndrome type 1. Cell Transplant. 14:151‐157.
  Anonymous. 2011. OPTN/SRTR 2010 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare System Bureau, Division of Transplantation, Rockville, Maryland.
  Anonymous. 2012. Organ Datasource Liver. Health and Resources and Services Administration, U.S. Department of Health & Human Services.
  Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al‐Dhalimy, M., Ellis, E., Strom, S., Kay, M.A., Finegold, M., and Grompe, M. 2007. Robust expansion of human hepatocytes in Fah–/–/Rag2–/–/Il2rg–/– mice. Nat. Biotechnol. 25:903‐910.
  Baccarani, U., Adani, G.L., Sanna, A., Avellini, C., Sainz‐Barriga, M., Lorenzin, D., Montanaro, D., Gasparini, D., Risaliti, A., Donini, A., and Bresadola, F. 2005. Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient. Transplant Internat. 18:750‐754.
  Ballinger, W.F. and Lacy, P.E. 1972. Transplantation of intact pancreatic islets in rats. Surgery 72:175‐186.
  Baumgartner, D., LaPlante‐O'Neill, P.M., Sutherland, D.E., and Najarian, J.S. 1983. Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D‐galactosamine‐induced liver failure in rats. Eur. Surg. Res. 15:129‐135.
  Berry, M.N. and Friend, D.S. 1969. High‐yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J. Cell Biol. 43:506‐520.
  Bilir, B.M., Guinette, D., Karrer, F., Kumpe, D.A., Krysl, J., Stephens, J., McGavran, L., Ostrowska, A., and Durham, J. 2000. Hepatocyte transplantation in acute liver failure. Liver Transpl. 6:32‐40.
  Bismuth, H. and Houssin, D. 1984. Reduced‐sized orthotopic liver graft in hepatic transplantation in children. Surgery 95:367‐370.
  Bohnen, N.I., Charron, M., Reyes, J., Rubinstein, W., Strom, S.C., Swanson, D., and Towbin, R. 2000. Use of indium‐111‐labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin. Nucl. Med. 6:447‐450.
  Darwish, A.A., Sokal, E., Stephenne, X., Najimi, M., de Goyet Jde, V., and Reding, R. 2004. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl. 10:1213‐1215.
  Demetriou, A.A., Reisner, A., Sanchez, J., Levenson, S.M., Moscioni, A.D., and Chowdhury, J.R. 1988. Transplantation of microcarrier‐attached hepatocytes into 90% partially hepatectomized rats. Hepatology 8:1006‐1009.
  De Vree, J.M., Ottenhoff, R., Bosma, P.J., Smith, A.J., Aten, J., and Oude Elferink, R.P. 2000. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119:1720‐1730.
  Dhawan, A., Mitry, R.R., Hughes, R.D., Lehec, S., Terry, C., Bansal, S., Arya, R., Wade, J.J., Verma, A., Heaton, N.D., Rela, M., and Mieli‐Vergani, G. 2004. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78:1812‐1814.
  Dhawan, A., Mitry, R.R., and Hughes, R.D. 2006. Hepatocyte transplantation for liver‐based metabolic disorders. J. Inherit. Metab. Dis. 29:431‐435.
  Dhawan, A., Puppi, J., Hughes, R.D., and Mitry, R.R. 2010. Human hepatocyte transplantation: Current experience and future challenges. Nat. Rev. Gastroenterol. Hepatol. 7:288‐298.
  Emond, J.C., Whitington, P.F., Thistlethwaite, J.R., Alonso, E.M., and Broelsch, C.E. 1989. Reduced‐size orthotopic liver transplantation: Use in the management of children with chronic liver disease. Hepatology 10:867‐872.
  Fisher, R.A. and Strom, S.C. 2006. Human hepatocyte transplantation: Worldwide results. Transplantation 82:441‐449.
  Fisher, R.A., Bu, D., Thompson, M., Tisnado, J., Prasad, U., Sterling, R., Posner, M., and Strom, S. 2000. Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation 69:303‐307.
  Fox, I.J., Chowdhury, J.R., Kaufman, S.S., Goertzen, T.C., Chowdhury, N.R., Warkentin, P.I., Dorko, K., Sauter, B.V., and Strom, S.C. 1998. Treatment of the Crigler‐Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338:1422‐1426.
  Gagandeep, S., Rajvanshi, P., Sokhi, R.P., Slehria, S., Palestro, C.J., Bhargava, K.K., and Gupta, S. 2000. Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride‐induced cirrhosis. J. Pathol. 191:78‐85.
  Giansily‐Blaizot, M., Verdier, R., Biron‐Adreani, C., Schved, J.F., Bertrand, M.A., Borg, J.Y., Le Cam‐Duchez, V., Briquel, M.E., Chambost, H., Pouymayou, K., Dutrillaux, F., Favier, R., Martin‐Toutain, I., Verdy, E., Gay, V., Goudemand, J., Navarro, R., Durin, A., d'Oiron, R., Lambert, T., Pernod, G., Barrot, C., Peynet, J., Bastenaire, B., Sie, P., Stieltjes, N., Torchet, M.F., and de Moerloose, P. 2004. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: Can biological tests predict the bleeding risk? Haematologica 89:704‐709.
  Goodrich, E.O. Jr., Welch, H.F., Nelson, J.A., Beecher, T.S., and Welch, C.S. 1956. Homotransplantation of the canine liver. Surgery 39:244‐251.
  Gramignoli, R., Green, M.L., Tahan, V., Dorko, K., Skvorak, K.J., Marongiu, F., Zao, W., Venkataramanan, R., Ellis, E.C., Geller, D., Breite, A.G., Dwulet, F.E., McCarthy, R.C., and Strom, S.C. 2011. Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant. 21:1245‐1260.
  Gramignoli, R., Dorko, K., Tahan, V., Skvorak, K.J., Ellis, E., Jorns, C., Ericzon, B.G., Fox, I.J., and Strom, S.C. 2013. Hypothermic storage of human hepatocytes for transplantation. Cell Transplant [Epub ahead of print].
  Gramignoli, R., Tahan, V., Dorko, K., Venkataramanan, R., Fox, I.J., Ellis, E.C., Vosough, M., and Strom, S.C. 2014. Rapid‐and‐sensitive assessment of human hepatocyte functions. Cell Transplant [Epub ahead of print].
  Grisham, J.W., Leong, G.F., and Hole, B.V. 1964. Heterotopic partial autotransplantation of rat liver: Technic and demonstration of structure and function of the graft. Cancer Res. 24:1474‐1495.
  Grossman, M., Rader, D.J., Muller, D.W., Kolansky, D.M., Kozarsky, K., Clark, B.J. 3rd, Stein, E.A., Lupien, P.J., Brewer, H.B. Jr., Raper, S.E., and Wilson, J.M. 1995. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat. Med. 1:1148‐1154.
  Groth, C.G., Arborgh, B., Bjorken, C., Sundberg, B., and Lundgren, G. 1977. Correction of hyperbilirubinemia in the glucuronyltransferase‐deficient rat by intraportal hepatocyte transplantation. Transplant. Proc. 9:313‐316.
  Gunsalus, J.R., Brady, D.A., Coulter, S.M., Gray, B.M., and Edge, A.S. 1997. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat. Med. 3:48‐53.
  Habibullah, C.M., Syed, I.H., Qamar, A., and Taher‐Uz, Z. 1994. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58:951‐952.
  Hamaguchi, H., Yamaguchi, Y., Goto, M., Misumi, M., Hisama, N., Miyanari, N., Mori, K., and Ogawa, M. 1994. Hepatic biliary transport after hepatocyte transplantation in Eizai hyperbilirubinemic rats. Hepatology 20:220‐224.
  Hiraoka, T., Hagerstrand, I., and Bengmark, S. 1983. Attempts at autologous transplantation of sliced liver to the subcutaneous tissue. Eur. Surg. Res. 15:37‐44.
  Horslen, S.P., McCowan, T.C., Goertzen, T.C., Warkentin, P.I., Cai, H.B., Strom, S.C., and Fox, I.J. 2003. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262‐1267.
  Hughes, R.D., Mitry, R.R., Dhawan, A., Lehec, S.C., Girlanda, R., Rela, M., Heaton, N.D., and Mueisan, P. 2006. Isolation of hepatocyte from livers from non‐heart‐beating donors for cell transplantation. Liver Transplant. 12:713‐717.
  Irani, A.N., Malhi, H., Slehria, S., Gorla, G.R., Volenberg, I., Schilsky, M.L., and Gupta, S. 2001. Correction of liver disease following transplantation of normal rat hepatocytes into Long‐Evans Cinnamon rats modeling Wilson's disease. Mol. Ther. 3:302‐309.
  Jiang, B., Kasai, S., Sawa, M., Hirai, S., Yamamoto, T., Ebata, H., and Mito, M. 1993. Beneficial effect of hepatic stimulatory substances on the survival of intrasplenically transplanted hepatocytes. Cell Transplant. 2:325‐329.
  Khan, A.A., Habeeb, A., Parveen, N., Naseem, B., Babu, R.P., Capoor, A.K., and Habibullah, C.M. 2004. Peritoneal transplantation of human fetal hepatocytes for the treatment of acute fatty liver of pregnancy: A case report. Trop. Gastroenterol. 25:141‐143.
  Khan, A.A., Parveen, N., Mahaboob, V.S., Rajendraprasad, A., Ravindraprakash, H.R., Venkateswarlu, J., Rao, P., Pande, G., Narusu, M.L., Khaja, M.N., Pramila, R., Habeeb, A., and Habibullah, C.M. 2008a. Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: A case report. Transplant. Proc. 40:1153‐1155.
  Khan, A.A., Parveen, N., Mahaboob, V.S., Rajendraprasad, A., Ravindraprakash, H.R., Venkateswarlu, J., Rao, P., Pande, G., Narusu, M.L., Khaja, M.N., Pramila, R., Habeeb, A., and Habibullah, C.M. 2008b. Treatment of Crigler‐Najjar Syndrome type 1 by hepatic progenitor cell transplantation: A simple procedure for management of hyperbilirubinemia. Transplant. Proc. 40:1148‐1150.
  Kmiec, Z. 2001. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 161:1‐151.
  Kobayashi, N., Ito, M., Nakamura, J., Cai, J., Hammel, J.M., and Fox, I.J. 2000. Treatment of carbon tetrachloride and phenobarbital‐induced chronic liver failure with intrasplenic hepatocyte transplantation. Cell Transplant. 9:671‐673.
  Koenig, S., Stoesser, C., Krause, P., Becker, H., and Markus, P.M. 2005. Liver repopulation after hepatocellular transplantation: Integration and interaction of transplanted hepatocytes in the host. Cell Transplant. 14:31‐40.
  Laconi, S., Pillai, S., Porcu, P.P., Shafritz, D.A., Pani, P., and Laconi, E. 2001. Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am. J. Pathol. 158:771‐777.
  Lacy, P.E. and Kostianovsky, M. 1967. Method for the isolation of intact Islets of Langerhans from the rat pancreas. Diabetes 16:35‐39.
  Lee, K.W., Lee, J.H., Shin, S.W., Kim, S.J., Joh, J.W., Lee, D.H., Kim, J.W., Park, H.Y., Lee, S.Y., Lee, H.H., Park, J.W., Kim, S.Y., Yoon, H.H., Jung, D.H., Choe, Y.H., and Lee, S.K. 2007. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant. 16:629‐637.
  Lysy, P.A., Najimi, M., Stephenne, X., Bourgois, A., Smets, F., and Sokal, E.M. 2008. Liver cell transplantation for Crigler‐Najjar syndrome type I: Update and perspectives. World J. Gastroenterol. 14:3464‐3470.
  Malhi, H., Gorla, G.R., Irani, A.N., Annamaneni, P., and Gupta, S. 2002a. Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia‐reperfusion leads to extensive liver repopulation. Proc. Natl. Acad. Sci. U.S.A. 99:13114‐13119.
  Malhi, H., Irani, A.N., Volenberg, I., Schilsky, M.L., and Gupta, S. 2002b. Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 122:438‐447.
  Matas, A.J., Sutherland, D.E., Steffes, M.W., Mauer, S.M., Sowe, A., Simmons, R.L., and Najarian, J.S. 1976. Hepatocellular transplantation for metabolic deficiencies: Decrease of plasma bilirubin in Gunn rats. Science 192:892‐894.
  Meyburg, J., Das, A.M., Hoerster, F., Lindner, M., Kriegbaum, H., Engelmann, G., Schmidt, J., Ott, M., Pettenazzo, A., Luecke, T., Bertram, H., Hoffmann, G.F., and Burlina, A. 2009. One liver for four children: First clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87:636‐641.
  Meyburg, J., Hoerster, F., Schmidt, J., Poeschl, J., Hoffmann, G.F., and Schenk, J.P. 2010. Monitoring of intraportal liver cell application in children. Cell Transplant. 19:629‐638.
  Mito, M., Kusano, M., and Sawa, M. 1993. Hepatocyte transplantation for hepatic failure. Transplant Rev. 7:35.
  Moscioni, A.D., Roy‐Chowdhury, J., Barbour, R., Brown, L.L., Roy‐Chowdhury, N., Competiello, L.S., Lahiri, P., and Demetriou, A.A. 1989. Human liver cell transplantation. Prolonged function in athymic‐Gunn and athymic‐analbuminemic hybrid rats. Gastroenterology 96:1546‐1551.
  Muraca, M., Gerunda, G., Neri, D., Vilei, M.T., Granato, A., Feltracco, P., Meroni, M., Giron, G., and Burlina, A.B. 2002. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317‐318.
  Nakazawa, F., Onodera, K., Kato, K., Sawa, M., Kino, Y., Imai, M., Kasai, S., Mito, M., Matsushita, T., and Funatsu, K. 1996. Multilocational hepatocyte transplantation for treatment of congenital ascorbic acid deficiency rats. Cell Transplant. 5:S23‐S25.
  Overturf, K., al‐Dhalimy, M., Ou, C.N., Finegold, M., and Grompe, M. 1997. Serial transplantation reveals the stem‐cell‐like regenerative potential of adult mouse hepatocytes. Am. J. Pathol. 151:1273‐1280.
  Puppi, J., Tan, N., Mitry, R.R., Hughes, R.D., Lehec, S., Mieli‐Vergani, G., Karani, J., Champion, M.P., Heaton, N., Mohamed, R., and Dhawan, A. 2008. Hepatocyte transplantation followed by auxiliary liver transplantation–A novel treatment for ornithine transcarbamylase deficiency. Am. J. Transplant. 8:452‐457.
  Ringe, B., Burdelski, M., Rodeck, B., and Pichlmayr, R. 1990. Experience with partial liver transplantation in Hannover. Clin. Transpl. 1990:135‐144.
  Rugstad, H.E., Robinson, S.H., Yannoni, C., and Tashjian, A.H. Jr. 1970a. Metabolism of bilirubin by a clonal strain of rat hepatoma cells. J. Cell. Biol. 47:703‐710.
  Rugstad, H.E., Robinson, S.H., Yannoni, C., and Tashjian, A.H. Jr. 1970b. Transfer of bilirubin uridine diphosphate‐glucuronyltransferase to enzyme‐deficient rats. Science 170:553‐555.
  Schneider, A., Attaran, M., Meier, P.N., Strassburg, C., Manns, M.P., Ott, M., Barthold, M., Arseniev, L., Becker, T., and Panning, B. 2006. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 82:1115‐1116.
  Shani‐Peretz, H., Tsiperson, V., Shoshani, G., Veitzman, E., Neufeld, G., and Baruch, Y. 2005. HVEGF165 increases survival of transplanted hepatocytes within portal radicles: Suggested mechanism for early cell engraftment. Cell Transplant. 14:49‐57.
  Skvorak, K.J., Hager, E.J., Arning, E., Bottiglieri, T., Paul, H.S., Strom, S.C., Homanics, G.E., Sun, Q., Jansen, E.E., Jakobs, C., Zinnanti, W.J., and Gibson, K.M. 2009a. Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim. Biophys. Acta 1792:1004‐1010.
  Skvorak, K.J., Paul, H.S., Dorko, K., Marongiu, F., Ellis, E., Chace, D., Ferguson, C., Gibson, K.M., Homanics, G.E., and Strom, S.C. 2009b. Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther. 17:1266‐1273.
  Slehria, S., Rajvanshi, P., Ito, Y., Sokhi, R.P., Bhargava, K.K., Palestro, C.J., McCuskey, R.S., and Gupta, S. 2002. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatoy perturbations in the liver. Hepatalogy 35:1320‐1328.
  Sokal, E.M., Smets, F., Bourgois, A., Van Maldergem, L., Buts, J.P., Reding, R., Bernard Otte, J., Evrard, V., Latinne, D., Vincent, M.F., Moser, A., and Soriano, H.E. 2003. Hepatocyte transplantation in a 4‐year‐old girl with peroxisomal biogenesis disease: Technique, safety, and metabolic follow‐up. Transplantation 76:735‐738.
  Soriano, H.E., Superina, R., Ferry, G.D., Wang, L., Alonso, E., Almond, S., Wood, R.P., and Whitington, P.F. 2001. Hepatocyte transplantation (HTX) in children with liver failure. Hepatology AASLD Abstracts October 2011.
  Starzl, T.E., Marchioro, T.L., Vonkaulla, K.N., Hermann, G., Brittain, R.S., and Waddell, W.R. 1963. Homotransplantation of the liver in humans. Surg. Gynecol. Obstet. 117:659‐676.
  Stephenne, X., Najimi, M., Smets, F., Reding, R., de Ville de Goyet, J., and Sokal, E.M. 2005. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am. J. Transplant. 5:2058‐2061.
  Stephenne, X., Najimi, M., Sibille, C., Nassogne, M.C., Smets, F., and Sokal, E.M. 2006. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130:1317‐1323.
  Strom, S.C., Fisher, R.A., Rubinstein, W.S., Barranger, J.A., Towbin, R.B., Charron, M., Mieles, L., Pisarov, L.A., Dorko, K., Thompson, M.T., and Reyes, J. 1997a. Transplantation of human hepatocytes. Transplant. Proc. 29:2103‐2106.
  Strom, S.C., Fisher, R.A., Thompson, M.T., Sanyal, A.J., Cole, P.E., Ham, J.M., and Posner, M.P. 1997b. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559‐569.
  Strom, S.C., Chowdhury, J.R., and Fox, I.J. 1999. Hepatocyte transplantation for the treatment of human disease. Semin. Liver Dis. 19:39‐48.
  Strom, S.C., Davila, J., and Grompe, M. 2010. Chimeric mice with humanized liver: Tools for the study of drug metabolism, excretion, and toxicity. Methods Mol. Biol. 640:491‐509.
PDF or HTML at Wiley Online Library